한글목차

세계의 압타머 시장은 2025년에 86억 달러로 추정되며, 2032년에는 274억 2,000만 달러에 달할 것으로 예측되며, 2025-2032년에 18.0%의 CAGR로 성장할 것으로 예측됩니다.

도표. 2025년 지역별 압타머 시장 점유율(%)

압타머는 특정 표적 분자에 결합하는 단일 가닥의 데옥시리보핵산(DNA) 또는 리보핵산(RNA) 분자입니다. 압타머는 화학적으로 합성할 수 있으며, 단백질, 저분자, 세포 표면의 표적 분자를 높은 친화력과 특이성으로 인식하고 결합합니다. 압타머는 항체에 비해 크기가 작고, 제조 및 변형이 용이하며, 면역원성이 없고, 조직으로의 침투성이 높다는 장점이 있습니다. 압타머는 연구, 진단, 치료 등 다양한 분야에서 응용되고 있습니다.

시장 역학

세계 압타머 시장의 성장은 생명과학 및 제약 산업의 R&D 투자 증가가 주도하고 있습니다. 또한 압타머는 그 장점으로 인해 진단 및 연구에서 항체의 대체품으로 사용되는 경우가 증가하고 있으며, 이는 시장 성장을 가속하고 있습니다. 그러나 압타머의 개발 및 생산과 관련된 높은 비용은 시장 성장을 저해하는 주요 요인으로 작용하고 있습니다. 압타머를 보다 간편하고 비용 효율적으로 생산할 수 있는 새로운 기술의 출현은 시장 참여자들에게 큰 기회를 제공합니다.

본 조사의 주요 특징

• 세계의 압타머(Aptamer) 시장을 상세하게 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모(10억 달러)와 연평균 성장률(CAGR)에 대해 조사 분석하여 전해드립니다.
• 또한 다양한 부문에 걸친 잠재적 매출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 주요 인사이트를 제공합니다.
• 이 보고서에서는 기업 개요, 제품 포트폴리오, 주요 특징, 주요 성과, 전략 등의 매개변수를 기반으로 Aptamer 세계 시장내 주요 기업 개요을 수록했습니다.
• 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 세계 압타머 시장은 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
• 세계 압타머 시장을 분석할 때 사용되는 다양한 전략 매트릭스를 통해 이해관계자들은 쉽게 의사결정을 내릴 수 있습니다.

목차

제1장 조사의 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 리포트 설명
  • 시장의 정의와 범위
• 개요
• COM(Coherent Opportunity Map)(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 촉진요인
  • 억제요인
  • 기회
• 영향 분석
• 시장 동향
• 규제 시나리오
• 제조업체 매출
• 인수와 제휴 시나리오
• 제품 발매/승인
• 자금조달과 투자
• PEST 분석
• Porter의 산업 분석

제4장 세계의 압타머 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• 전체적인 영향
• 정부 구상
• 시장에 대한 COVID-19의 영향

제5장 세계의 압타머 시장, 유형별, 2020-2032년(10억 달러)

• 서론
• 핵산
• 펩티드 압타머

제6장 세계의 압타머 시장, 용도별, 2020-2032년(10억 달러)

• 서론
• 진단
• 치료
• 연구개발

제7장 세계의 압타머 시장, 최종사용자별, 2020-2032년(10억 달러)

• 서론
• 바이오테크놀러지와 제약 기업
• 학술연구기관
• 계약 연구기관

제8장 세계의 압타머 시장, 지역별, 2020-2032년(10억 달러)

• 서론
• 북미
• 라틴아메리카
• 유럽
• 아시아태평양
• 중동
• 아프리카

제9장 경쟁 구도

• 기업 개요
  • AstraZeneca
  • Achiko AG
  • Agilent Technologies, Inc.
  • Amsbio
  • Aptagen LLC
  • Aptamer Group
  • CAGE Bio Inc.
  • GC Biopharma Corp.
  • GlyTech, Inc.
  • IVERIC bio, Inc.
  • NeoNeuro SAS
  • Novartis AG
  • Ophthotech Corporation
  • SomaLogic Operating Co., Inc.
  • TAGCyx BIoTechnologies Inc.
  • Vivonics Inc.
  • Zentek Ltd.

제10장 애널리스트의 권장사항

• 운명의 수레바퀴
• COM(Coherent Opportunity Map)

제11장 참고 문헌과 조사 방법

• 참고 문헌
• 조사 방법

영문목차

Global Aptamers Market is estimated to be valued at USD 8.60 Bn in 2025 and is expected to reach USD 27.42 Bn by 2032, growing at a compound annual growth rate (CAGR) of 18.0% from 2025 to 2032.

Figure. Aptamers Market Share (%), By Region 2025

Aptamers are single stranded Deoxyribonucleic acid (DNA) or Ribonucleic acid (RNA) molecules that bind to a specific target molecule. These can be chemically synthesized to recognize and bind protein, small molecule or cell surface targets with high affinity and specificity. Aptamers have several advantages over antibodies such as small size, easy production and modification, lack of immunogenicity and better tissue penetration. These have wide applications in research, diagnostics, therapeutics and others.

Market Dynamics:

Global aptamers market growth is driven by rising research and development investments in life sciences and pharmaceutical industries. Growing use of aptamers as an alternative to antibodies in diagnostics and research due to their advantages is also boosting the market growth. However, high costs associated with aptamer development and production is a major factor hampering the market growth. Emergence of novel technologies for simpler and cost-effective production of aptamers provides a significant opportunity for market players.

Key Features of the Study:

• This report provides in-depth analysis of the global aptamers market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global aptamers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study AstraZeneca, Achiko AG, Agilent Technologies, Inc., Amsbio, Aptagen LLC, Aptamer Group, CAGE Bio Inc., GC Biopharma Corp., GlyTech, Inc., IVERIC bio, Inc., NeoNeuro SAS, Novartis AG, Ophthotech Corporation, SomaLogic Operating Co., Inc., TAGCyx Biotechnologies Inc., Vivonics Inc., Zentek Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global aptamers market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global aptamers market.

Detailed Segmentation-

• By Type:
  • Nucleic Acid
  • DNA-based Aptamers
  • RNA-based Aptamers
  • XNA-based Aptamers
  • Peptide Aptamers
• By Application:
  • Diagnostics
  • Therapeutics
  • Research and Development
• By End User:
  • Biotechnology and Pharmaceutical Companies
  • Academic and Research Institutions
  • Contract Research Organization
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • AstraZeneca
  • Achiko AG
  • Agilent Technologies, Inc.
  • Amsbio
  • Aptagen LLC,
  • Aptamer Sciences, Inc.
  • CAGE Bio Inc.
  • GC Biopharma Corp.
  • GlyTech, Inc.
  • IVERIC bio, Inc.
  • NeoNeuro SAS
  • Novartis AG
  • Ophthotech Corporation
  • SomaLogic Operating Co., Inc.
  • TAGCyx Biotechnologies Inc.
  • Vivonics Inc.
  • Zentek Ltd.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Manufacturer Revenue
• Acquisitions and Partnerships Scenario
• Product Launches/Approvals
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Aptamers Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the market

5. Global Aptamers Market, By Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Nucleic Acid
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • DNA-based Aptamers
  • RNA-based Aptamers
  • XNA-based Aptamers
• Peptide Aptamers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Aptamers Market, By Application, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Diagnostics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Therapeutics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Research and Development
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Aptamers Market, By End User, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Biotechnology and Pharmaceutical Companies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Academic and Research Institutions
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Contract Research Organization
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Aptamers Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • U.S.
  • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

• Company Profiles
  • AstraZeneca
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Achiko AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Agilent Technologies, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Amsbio
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Aptagen LLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Aptamer Group
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • CAGE Bio Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • GC Biopharma Corp.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • GlyTech, Inc.
  • IVERIC bio, Inc.
  • NeoNeuro SAS
  • Novartis AG
  • Ophthotech Corporation
  • SomaLogic Operating Co., Inc.
  • TAGCyx Biotechnologies Inc.
  • Vivonics Inc.
  • Zentek Ltd.

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact

"